 |
 |
 |
 |
 |
||||||||||||||
Overactive Bladder Syndrome A 10-Week, Phase 2 Clinical Study of an Investigational Oral Medication for the Treatment of Patients with Overactive Bladder Syndrome Why This Trial Is Important Overactive Bladder Syndrome (OABS) may affect up to 17% of adults. Surveys of patients affected by OABS suggest that its symptoms of urinary urgency, frequency, and nocturia have a greater effect on quality of life than chronic pathological conditions such as Diabetes and Osteoporosis.
A clinical trial is currently being conducted in our practice that utilizes an investigational treatment for Overactive Bladder Syndrome. All office visits, medical evaluations, and investigational medications related to the study will be provided at no cost to the patient. Who Can Join This Trial? Patients who suffer from OABS and are between the ages of 20 and 80 years of age may be eligible to participate. If you are interested in participating in this trial, please contact us for a complete list of inclusion/exclusion criteria or to schedule a screening visit. Study Site and Contact Information Southeastern Research Group, INc. Please contact us if you are interested in more information about this study. |
|
|||||||||||||||
 |
 |
